| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |